Trientine Dihydrochloride
Triethylenetetramine is a copper chelating agent used for the management of Wilson’s disease in cases where penicillamine therapy is clinically inappropriate.
Systematic Name
(2-Aminoethyl)({2-[(2-aminoethyl)amino]ethyl})amine dihydrochloride
Therapeutic Category
Wilson's disease
Suitable Formulations
Solid
Approvals
US DMF, TGA, TDMF
EU-WC